Indoco Remedies Ltd Quarterly Result
Indoco Remedies Ltd
NSE: INDOCO
Net Profit - Last Quarter
Indoco Remedies Ltd Quarterly Results Key Highlights
- The revenue of Indoco Remedies Ltd for the Jun '26 is ₹ 567.02 crore as compare to the Mar '26 revenue of ₹ 479.31 crore.
- This represent the growth of 18.3% The ebitda of Indoco Remedies Ltd for the Jun '26 is ₹ 140.54 crore as compare to the Mar '26 ebitda of ₹ 53.41 crore.
- This represent the growth of 163.13% The net profit of Indoco Remedies Ltd for the Jun '26 is ₹ 65.44 crore as compare to the Mar '26 net profit of ₹ -23.68 crore.
- This represent the decline of -376%.
Indoco Remedies Ltd Quarterly Results Analysis
Market Price of Indoco Remedies Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 29 Jul 2026 | 225.15 |
| 28 Jul 2026 | 228.1 |
| 27 Jul 2026 | 247.75 |
| 24 Jul 2026 | 242 |
| 23 Jul 2026 | 237.55 |
| 22 Jul 2026 | 233.4 |
| 21 Jul 2026 | 245.95 |
| 20 Jul 2026 | 245.1 |
| 17 Jul 2026 | 246.65 |
| 16 Jul 2026 | 252.25 |
Historical Revenue of Indoco Remedies Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Indoco Remedies Ltd
Historical EBITDA of Indoco Remedies Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Indoco Remedies Ltd
Historical Net Profit of Indoco Remedies Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Indoco Remedies Ltd
Indoco Remedies Ltd News Hub
Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg
Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New Drug Appl
Read more
21 Aug 24
Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets
The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been granted a Comp
Read more
21 Aug 24
Indoco Remedies fixes record date for final dividend
Indoco Remedies has fixed 19 September 2024 as record date for determining entitlement of members to
Read more
30 Aug 24
Indoco Remedies AGM scheduled
Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be held on 26 Se
Read more
31 Aug 24
Document
Popular Search
About Indoco Remedies Ltd
- Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
- The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
- The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.
